Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Studies of Elevated Parathyroid Activity
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), October 2008
Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001277
  Purpose

Patients whose parathyroid activity is elevated above normal are referred to as having hyperparathyroidism. This study will help researchers better understand the causes of hyperthyroidism and to evaluate and improve methods for diagnosis and treatment.

In this study, patients diagnosed with or suspected of having hyperparathyroidism will be selected to participate. In addition, patients with related conditions such as parathyroid tumors, will also be selected.

Subjects will be asked to provide blood and urine for testing to confirm their condition. They will then be surgically treated by removal of the parathyroid gland(s) (parathyroidectomy).

Subjects with parathyroid tumors will undergo several diagnostic tests to determine the exact location of the tumor as well as the tumor's activity. The tests may include; ultrasounds, nuclear scanning, CT scans, MRI, and specialized blood testing.

Sometimes parathyroidectomy leads to hypoparathyroidism. Options for treating the patients after the surgical procedure will also be addressed. Calcium and Vitamin D supplements are typically the mainstay of post parathyroidectomy therapy. Other potential treatments include transplanting the parathyroid gland(s) to other areas of the body.


Condition
Hyperparathyroidism
Hypocalcemia
Hypoparathyroidism
Parathyroid Neoplasm

MedlinePlus related topics: Calcium Cancer
Drug Information available for: Parathyroid Calcium gluconate Vitamin D Ergocalciferol
U.S. FDA Resources
Study Type: Observational
Official Title: Studies of Hyperparathyroidism and Related Disorders

Further study details as provided by National Institutes of Health Clinical Center (CC):

Study Start Date: March 1991
Detailed Description:

Patients with confirmed or suspected primary hyperparathyroidism or complications therefrom (such as postoperative hypoparathyroidism) will be admitted for diagnosis and treatment. Patients with moderately severe primary hyperparathyroidism will be treated. The principal diagnostic components are calcium in serum and urine and parathyroid hormone in serum. Treatment will be mainly by parathyroidectomy.

Preoperative testing to localize parathyroid neoplasm(s) will be used usually and with more extended methods in cases with prior neck surgery. Preoperative tumor localization tests will be selected according to clinical indications from the following: ultrasound, technetium-thallium scan, computerized tomography, magnetic resonance imaging, fine needle aspiration for parathyroid hormone assay, arteriogram, selective venous catheterization for parathyroid hormone assay. Options for management of postoperative hypocalcemia include calcium, vitamin D preparations, parathyroid autografts and synthetic parathyroid hormone. Research specimens may consist of blood or tumors.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Patients (male or female any age) with known or suspected primary hyperparathyroidism or a related disorder (such as familial multiple endocrine neoplasia type 1 [FMEN1]) will be evaluated.

The vast majority of patients will be greater than age 18.

In the rare occasion where special resources might be appropriate (uremic patient, young child), the availability of special resources would be confirmed prior to admission.

EXCLUSION CRITERIA:

There are no absolute exclusions.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001277

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, Maryland
United Services University of Health Services Recruiting
Bethesda, Maryland, United States, 20889
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site

Publications:
Study ID Numbers: 910085, 91-DK-0085
Study First Received: November 3, 1999
Last Updated: December 20, 2008
ClinicalTrials.gov Identifier: NCT00001277  
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Parathyroid
Calcium
Vitamin D

Study placed in the following topic categories:
Parathyroid Diseases
Hypocalcemia
Metabolic Diseases
Ergocalciferols
Endocrine System Diseases
Calcium, Dietary
Parathyroid Neoplasms
Vitamin D
Hyperparathyroidism
Head and Neck Neoplasms
Water-Electrolyte Imbalance
Hypoparathyroidism
Endocrinopathy
Metabolic disorder
Endocrine Gland Neoplasms

Additional relevant MeSH terms:
Calcium Metabolism Disorders
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 15, 2009